SB
NVO

Strategic Blueprint’s Novo Nordisk NVO Stock Holding History

Strategic Blueprint’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,797
Closed -$214K – 690
2024
Q3 		$214K Sell
1,797
-115
-6% -$15.3K 0.01% 609
2024
Q2 		$273K Sell
1,912
-332
-15% -$44K 0.02% 514
2024
Q1 		$288K Buy
2,244
+302
+16% +$36K 0.02% 502
2023
Q4 		$201K Buy
+1,942
New +$192K 0.02% 540
2021
Q3 		– Sell
-486
Closed -$20K – 1012
2021
Q2 		$20K Buy
+486
New +$18.8K ﹤0.01% 818

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Strategic Blueprint's NVO Position: Q4 2024 in Review

Strategic Blueprint sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,797 shares — an estimated $214K sold.

Strategic Blueprint first reported a position in NVO in Q2 2021 and held it in 5 quarters. The position peaked at $288K in Q1 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Strategic Blueprint reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Strategic Blueprint sold 1,797 Novo Nordisk shares in Q4 2024, an estimated $214K.
  • Strategic Blueprint first reported a position in Novo Nordisk in Q2 2021 and held it in 5 quarters.
  • Strategic Blueprint's Novo Nordisk position peaked at $288K in Q1 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Strategic Blueprint's 13F filing for Q4 2024, filed 23 Jan 2025.